Showing results (21-30 of 399) with videos related to
Sort By:
Pageof 40
BMC Immunology|August 29, 2023
HIV specific Th1 responses are altered in Ugandans with HIV and Schistosoma mansoni coinfectionAndrew Ekii Obuku, Jacqueline Kyosiimire Lugemwa, Andrew Abaasa, et al.Vaccine|August 17, 2004
Attenuated poxviruses expressing a synthetic HIV protein stimulate HLA-A2-restricted cytotoxic T-cell responsesArnaud Didierlaurent, Juan-Carlos Ramirez, Magdalena Gherardi, et al.The Journal of Experimental Medicine|June 11, 2024
Personalized cancer T-cell therapy takes the stage, mirroring vaccine successJohanna Chiffelle, Alexandre HarariThe Journal of Clinical Investigation|March 6, 2002
Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapyG Paolo Rizzardi, Alexandre Harari, Brunella Capiluppi, et al.Vaccine|June 20, 2008
A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell responseIsabelle Miconnet, Giuseppe PantaleoCurrent Opinion in HIV and AIDS|April 20, 2017
B-cell abnormalities and impact on antibody response in HIV infectionAlessandra Noto, Giuseppe PantaleoCurrent Opinion in HIV and AIDS|September 9, 2016
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm changeGiuseppe Pantaleo, Yves LevyCurrent Opinion in HIV and AIDS|March 13, 2013
Vaccine and immunotherapeutic interventionsGiuseppe Pantaleo, Yves LévyCancer Cell|July 12, 2022
Immune pressure sculps tumor cells and trims high-quality mutationsMichal Bassani-Sternberg, Alexandre HarariCancers|November 27, 2021
Vaccines as Priming Tools for T Cell Therapy for Epithelial CancersLana E Kandalaft, Alexandre HarariPageof 40